Chloroquine: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 March 2024

26 March 2024

19 March 2024

  • curprev 09:2309:23, 19 March 2024Lazy talk contribs 1,748 bytes +1,748 Created page with "{{TreatmentInfo |drug_name=Chloroquine and Hydroxychloroquine |FDA_approval=No (for glioblastoma treatment) |used_for=Glioblastoma, in combination with traditional chemotherapy agents |clinical_trial_phase=Reviewed in recent meta-analyses and studies |common_side_effects=Generally well-tolerated; specific studies noted minimal impact on adverse event incidence |OS_without=BCNU alone: median survival of 11 months |OS_with=Chloroquine with BCNU: median survival significant..."